With biotechnology stock valuations down for more than two years since peaking in February 2021, the industry has gotten somewhat used to volatility, but recent fluctuations paint a clear picture of h
Blackstone has raised a new fund called Blackstone Life Sciences Yield (BXLS Yield), providing $1.6bn in additional capital for drug, device and diagnostic developers with late-stage assets. But while